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Figure S1: Genetic context for RB50ΔbtrS mutant strain. Diagram showing the clean, in-frame 
deletion of the brpL/btrS gene (Locs_tag BB1638) in the RB50 B. bronchiseptica chromosome. 











































Figure S2: Macrophages at a confluency of 97-99% were challenged at an MOI of 100, n=6. (A) Percentage of 
macrophages containing the indicated number of bacteria at 15 minutes post-exposure. RB50 (blue) and 
RB50ΔbtrS (red) were enumerated using Transmission Electron Microscopy (TEM). TEM of RAW macrophages 
challenged for 4 hours with RB50 (B) (bacteria are shown in red) or with the mutant (C). (D) Cytotoxicity of RB50 
and RB50ΔbtrS at 15 min and 4 hours post-challenge. (E) IL-1β secreted measured at 15 min and 4 hours post-
challenged of macrophages challenged with wild-type or mutant B. bronchiseptica. (F) IL-6 secreted at 4 hours 
post-challenge with RB50 or RB50ΔbtrS. Statistical significance was calculated using Two-Way ANOVA. * p<0.05, 
** p<0.005, *** p<0.0005, and **** p<0.0001. Error bars indicate SEM.  
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Figure S3: Phenotypes that required btrS in vivo 
and in vitro. (A) Mice were intranasally challenged 
with RB50 (blue), RB50ΔbtrS (red), or RB50ΔbtrS::btrS 
(black). 28 days post-inoculation organs were harvest 
and bacterial load in the lungs was enumerated. (B) 
Motility assay was performed in 0.4% LB agar 
inoculated with 10µl of a liquid culture of RB50 or 
RB50ΔbtrS at an OD of 0.7. The plates were read at 24 
and 48 hours post-inoculation (n=4) (B) Mice were 
intranasally challenged with RB50 or RB50ΔbtrS and 
pathological studies (H&E) were performed. In the left 
is the zoom out and the right is the zoom in image of 



























Figure S4: Bacterial numbers isolated 
from nasal cavity, trachea, and lungs of 
Rag-/- mice.. Groups of 4 mice were 
challenged with a low dose (150 CFU) in a 
low volume (5mL) of wild-type (blue) or 
mutant (red) B. bronchiseptica at 24 days 
post-inoculation. Bacterial load from the 
respiratory tract organs was enumerated 
(n=2). Stat ist ical s igni f icance was 
calculated using Two-Way ANOVA. *** 
p<0.0005. Error bars indicate SEM. 





























B. parapertussisA B C 
Figure S5: Efficiency of RB50ΔbtrS as a vaccine against B. pertussis and B. parapertussis. (A) Mice were 
challenged with PBS (black), RB50 (blue), or RB50ΔbtrS (red). 3 months post-exposure, mice were inoculated 
with B. pertussis and sacrificed at day 7 (n=4). Bacterial load in the lungs was enumerated. (B-C) Mice were 
vaccinated with PBS (black), Adacel acellular vaccine (violet), or RB50ΔbtrS (red). 60 days later, mice were re-
challenged with (B) B. pertussis or (C) B. parapertussis and euthanized at day 7 (n=4).  
RB50 / RB50ΔbtrS B cells 
T cells 
Figure S6: Gating strategy utilized for flow cytometry. Strategies adapted 
from standard gating procedures (52) (n=6 per experiment of 4).  
Table S1. 
Antibodies used in this study are detailed on the table below. 
Laser	 BP	filter	 Fluorochromes	 Cytokine	 Vendor	 Reference	
488	Laser	
B	 525/50	 FitC	 GR1	 Tonbo	 35-5931
532	Laser	
E	 575/20	 PE	 CD11b	 Tonbo	 50-0112
488	Laser	
A	 695/40	 PerCP	 F4/80	 Tonbo	 65-4801
640	Laser	
C	 660/20	 APC	 CD19	 Tonbo	 20-0193
640	Laser	
A	 780/60	 APC-Cy7	 CD90.2	 BD	 561641	
405	Laser	
C	 450/50	 V450	 CD4	 Tonbo	 75-0041
404	Laser	
B	 525/50	 V500	 CD8	 BD	 563068	
